- Blockade of trans PD-L1 interaction with CD80 augments antitumor immunityZhang, Yuankun; Song, Qingxiao; Cassady, Kaniel; Lee, Michael; Tang, Haidong; Zheng, Moqian; Wang, Bixin; Schones, Dustin E.; Fu, Yang-Xin; Riggs, Arthur D.; Martin, Paul J.; Feng, Ru*; Zeng, Defu*PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120(16): e2205085120.被引 4
- Targeting the tumor microenvironment to enhance antitumor immune responsesVan der Jeught Kevin; Bialkowski Lukasz; Daszkiewicz Lidia; Broos Katrijn; Goyvaerts Cleo; Renmans Dries; Van Lint Sandra; Heirman Carlo; Thielemans Kris; Breckpot KarineONCOTARGET, 2015, 6(3): 1359-1381.
- Toward a new stage of PD-1 blockade cancer immunotherapyNagahiro, MinatoInternational Journal of Clinical Oncology, 2020, 25(5): 787-789.被引 3
会议论文
Blockade of PD-L1 interaction with CD80 in trans augments anti-tumor immunity by increasing NOS2 in tumor-associated macrophages.
9阅读
